Credit Acceptance Corp
CACC Nasdaq Personal Credit Institutions Financials FY2016βFY2025
What Credit Acceptance Corp does
No business description yet.
- Legal name
- CREDIT ACCEPTANCE CORP
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 13, 2026
- Accession Β· CIK
- 0000885550-26-000047
0000885550
Revenue and margins
Credit Acceptance Corp had $2.3B of revenue in fiscal 2025, up 7.2% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 9.3% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $1.1B in fiscal 2025, 45.4% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Credit Acceptance Corp returned $725M to shareholders in fiscal 2025, 69% of free cash flow. The diluted share count fell 6.6%.
Balance sheet
Cash, debt and the ratios that show how comfortably Credit Acceptance Corp can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $23.3M | $7.7M | $13.2M | $344M | $22.8M |
| Total assets | $7.1B | $6.9B | $7.6B | $8.9B | $8.6B |
| Total liabilities | $5.2B | $5.3B | $5.9B | $7.1B | $7.1B |
| Shareholders' equity | $1.8B | $1.6B | $1.8B | $1.7B | $1.5B |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 |
| Accruals ratio | β4.1% | β2.1% | β2.3% | β2.3% | β7.6% | β1.5% | β10.1% | β12.6% | β10.8% | β7.2% |
| Altman Z'' | β | β | β | β | β | β | β | β | β | β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $969M | $1.1B | $1.3B | $1.5B | $1.7B | $1.9B | $1.8B | $1.9B | $2.2B | $2.3B |
| Provision for credit losses | $90.2M | $129M | $56.9M | $76.4M | $557M | $8.4M | $481M | $736M | β | β |
| Interest expense | $97.7M | $120M | $157M | $196M | $192M | $164M | $167M | $267M | $420M | $463M |
| Pretax income | $531M | $584M | $755M | $856M | $550M | $1.3B | $712M | $368M | $330M | $565M |
| Income tax | $198M | $114M | $181M | $200M | $129M | $303M | $176M | $81.5M | $81.6M | $142M |
| Net income | $333M | $470M | $574M | $656M | $421M | $958M | $536M | $286M | $248M | $424M |
| Diluted EPS | $16.31 | $24.04 | $29.39 | $34.57 | $23.47 | $59.52 | $39.32 | $21.99 | $19.88 | $36.38 |
| Diluted shares | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.01B | 0.01B | 0.01B | 0.01B |
| Cash flow | ||||||||||
| Cash from operations | $507M | $566M | $704M | $812M | $985M | $1.1B | $1.2B | $1.2B | $1.1B | $1.1B |
| Capital expenditure | $5.5M | $8.4M | $25.1M | $26.8M | $8.5M | $7.6M | $3.1M | $4.0M | $1.8M | $1.6M |
| Free cash flow | $502M | $558M | $679M | $786M | $977M | $1.1B | $1.2B | $1.2B | $1.1B | $1.1B |
| Depreciation and amortization | $6.1M | $6.0M | $5.4M | $7.3M | $8.8M | $9.7M | $9.0M | $8.9M | $6.7M | $3.6M |
| Stock-based compensation | $7.4M | $15.4M | $10.3M | $7.6M | $6.2M | $24.8M | $36.5M | $39.1M | $45.0M | $50.7M |
| Share buybacks | $122M | $124M | $129M | $300M | $481M | $1.5B | $785M | $203M | $313M | $725M |
| Dividends and buybacks | $122M | $124M | $129M | $300M | $481M | $1.5B | $785M | $203M | $313M | $725M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $14.6M | $8.2M | $25.7M | $187M | $16.0M | $23.3M | $7.7M | $13.2M | $344M | $22.8M |
| Loans, net | $3.9B | $4.6B | $5.8B | $6.7B | $6.8B | $6.3B | $6.3B | $7.0B | β | β |
| Property and equipment, net | $18.2M | $20.5M | $40.2M | $59.7M | $59.4M | $57.3M | $51.4M | $46.5M | $14.7M | $12.6M |
| Total assets | $4.2B | $5.0B | $6.2B | $7.4B | $7.5B | $7.1B | $6.9B | $7.6B | $8.9B | $8.6B |
| Total liabilities | $3.0B | $3.4B | $4.2B | $5.1B | $5.2B | $5.2B | $5.3B | $5.9B | $7.1B | $7.1B |
| Preferred stock | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $1.2B | $1.5B | $2.0B | $2.4B | $2.3B | $1.8B | $1.6B | $1.8B | $1.7B | $1.5B |
| Margins | ||||||||||
| Net margin | 34.3% | 42.4% | 44.6% | 44.1% | 25.2% | 51.6% | 29.2% | 15.0% | 11.5% | 18.3% |
| FCF margin | 51.8% | 50.2% | 52.8% | 52.8% | 58.5% | 57.2% | 67.4% | 63.1% | 52.5% | 45.4% |
| Returns | ||||||||||
| Return on equity | 28.4% | 34.7% | 32.6% | 30.2% | 18.1% | 46.4% | 31.1% | 16.9% | 14.2% | 25.9% |
| Return on assets | 7.9% | 10.2% | 10.2% | 9.6% | 5.6% | 13.2% | 7.7% | 3.9% | 3.0% | 4.8% |
| Return on tangible equity | 28.4% | 30.6% | 28.8% | 27.9% | 18.3% | 52.5% | 33.0% | 16.3% | 14.2% | 27.8% |
| Growth | ||||||||||
| Revenue growth | β | 14.5% | 15.8% | 15.8% | 12.1% | 11.2% | β1.3% | 3.8% | 13.7% | 7.2% |
| Net income growth | β | 41.3% | 22.1% | 14.3% | β35.8% | 127.6% | β44.1% | β46.6% | β13.4% | 71.0% |
| EPS growth | β | 47.4% | 22.3% | 17.6% | β32.1% | 153.6% | β33.9% | β44.1% | β9.6% | 83.0% |
| FCF growth | β | 11.1% | 21.7% | 15.7% | 24.3% | 8.7% | 16.4% | β2.9% | β5.3% | β7.3% |
| Share count change | β | β4.2% | β0.1% | β2.8% | β5.5% | β10.2% | β15.4% | β4.5% | β4.2% | β6.6% |
| Financial health | ||||||||||
| Provision / loans | 2.3% | 2.8% | 1.0% | 1.1% | 8.2% | 0.1% | 7.6% | 10.6% | β | β |
| Capital allocation | ||||||||||
| Capex / revenue | 0.6% | 0.8% | 2.0% | 1.8% | 0.5% | 0.4% | 0.2% | 0.2% | 0.1% | 0.1% |
| Stock comp / revenue | 0.8% | 1.4% | 0.8% | 0.5% | 0.4% | 1.3% | 2.0% | 2.1% | 2.1% | 2.2% |
| Payouts / FCF | 24.3% | 22.1% | 19.0% | 38.2% | 49.2% | 138.6% | 63.5% | 16.9% | 27.6% | 68.9% |
| Quality scores | ||||||||||
| Accruals ratio | β4.1% | β2.1% | β2.3% | β2.3% | β7.6% | β1.5% | β10.1% | β12.6% | β10.8% | β7.2% |
Source: SEC EDGAR XBRL filings (CIK 0000885550). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.